SCHEMBL7992340

SCHEMBL7992340

CCc1nc(=O)c2c(ncn2Cc2cc(C(C)(C)C)c(OCc3ccccc3)c(C(C)(C)C)c2)[nH]1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 3/20 0.40
PARN O95453 1/20 0.40
SMN1; SMN2 Q16637 5/20 0.35
HPGD P15428 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HTT P42858 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPK14 Q16539 1/20 0.34
PNP P00491 1/20 0.34
BRD4 O60885 2/20 0.33
HCAR2 Q8TDS4 1/20 0.33
NPC1 O15118 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ADORA2B P29275 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
GAA P10253 1/20 0.33
GRK2 P25098 1/20 0.32
GRK1 Q15835 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987444 0.88 PARN (0.42) CNOT7PARNSMN1; SMN2HPGDALDH1A1
SCHEMBL7992335 0.85 HPGD (0.44) CNOT7PARNSMN1; SMN2HPGDALDH1A1
SCHEMBL7975254 0.83 CNOT7 (0.55) CNOT7PARNSMN1; SMN2HPGDALDH1A1
SCHEMBL7987785 0.82 PARN (0.47) CNOT7PARNSMN1; SMN2HPGDALDH1A1
SCHEMBL7985523 0.82 TDP1 (0.39) CNOT7PARNHPGDALDH1A1HTT
SCHEMBL7984470 0.77 ABCC8 (0.50) CNOT7PARNSMN1; SMN2HPGDMEN1
SCHEMBL7973938 0.77 CNOT7 (0.48) CNOT7PARNSMN1; SMN2HPGDALDH1A1
SCHEMBL7985476 0.77 CNOT7 (0.53) CNOT7PARNSMN1; SMN2HPGDALDH1A1
SCHEMBL7984380 0.76 CYP11B1 (0.40) CNOT7PARNSMN1; SMN2HPGDALDH1A1
SCHEMBL7985654 0.76 CNOT7 (0.42) CNOT7PARNSMN1; SMN2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed